| US: Sinovac's PANFLU.1 (H1N1) Regulatory Approval Expanded to Include Geriatric ...
Found: Tue Nov 17 08:47:56 2009 PST
Source: MSNBC (US Web)
Copyright: MSNBC
Contact: letters@msnbc.com
Website: http://msnbc.com/news/
Details: http://www.mapinc.org/media/938
Webpage: http://www.tradingmarkets.com/.site/news/S...
Newshawk: http://drugpolicycentral.com/bot/
| |
Sinovac's PANFLU.1 (H1N1) Regulatory Approval Expanded to Include Geriatric ... SVA Sinovac's PANFLU.1 (H1N1) Regulatory Approval Expanded to Include Geriatric Population
New book by Larry Connors Click here Improve your trading - See how
* PowerRatings
* Stock PowerRatings
* ETF PowerRatings
View More Topics }}
View Trading Glossary }}
Sinovac's PANFLU.1 (H1N1) Regulatory Approval Expanded to Include Geriatric Population
Tue. November 17, 2009; Posted: 11:25 AM
Mr. Weidong Yin, Chairman, President and CEO of Sinovac, stated, "The revised license enables Sinovac to provide our H1N1 vaccine to a broader population across China and lengthens the product shelf life. We continue to work closely with Chinese government to provide citizens with international-quality vaccines and to fulfill our mission of supplying vaccines to eliminate human diseases."
About Sinovac
Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases. Sinovac's vaccine products include Healive(R) (hepatitis A), Bilive(R) (combined hepatitis A and B), and Anflu(R) (influenza). PANFLU.1(TM), Sinovac's H1N1 vaccine, and Panflu(TM), Sinovac's pandemic influenza vaccine (H5N1), have already been approved for government stockpiling. Sinovac is developing vaccines for enterovirus 71, universal pandemic influenza, Japanese encephalitis vaccine, and human rabies vaccine. Its wholly owned subsidiary, Tangshan Yian, is has submitted an application for approval with the Ministry of Agriculture for its independently developed inactivated animal rabies vaccine.
Safe Harbor Statement
This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by words or phrases such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Among other things, the business outlook and quotations from management in this press release contain forward-looking statements. Statements that are not historical facts, including statements about Sinovac's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of important factors could cause actual results to differ materially from those contained in any forward-looking statement. Sinovac does not undertake any obligation to update any forward-looking statement, except as required under applicable law.
For further information, please contact:
Sinovac Biotech Ltd.
Helen G. Yang
Tel: +86-10-8289-0088 x9871
Fax: +86-10-6296-6910
Email: info@sinovac.com
Investors:
The Ruth Group
Amy Glynn/Stephanie Carrington
Tel: +1-646-536-7023/7017
Email: aglynn@theruthgroup.com
scarrington@theruthgroup.com
Media
The Ruth Group
Janine McCargo
Tel: +1-646-536-7033
Email: jmccargo@theruthgroup.com
SOURCE Sinovac Biotech Ltd. http://www.sinovac.com
For full details on Sinovac Biotech Ltd (SVA) click here. Sinovac Biotech Ltd (SVA) has Short Term PowerRatings of 5. Details on Sinovac Biotech Ltd (SVA) Short Term PowerRatings is available at This Link.
Email
Print
Add a note (optional)
Related News [SVA]
* Sinovac Biotech Ltd secures CNY20.6m order for hepatitis A vaccine
* Sinovac Reports Unaudited Third Quarter 2009 Financial Results
* PicksThatMove.com Announces Investment Opinion on American International Group Inc., JA Solar Holdin...
* Sinovac to Host Conference Call to Report 2009 Third Quarter Financial Results
* Sinovac Receives Purchase Order from Shanghai Government to Supply Hepatitis A Vaccine Healive(R)
UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
Thursday December 3 12:30 PM
Hear What Kevin Haggerty Sees in the Stock Market Today!
Tuesday November 24 04:30 PM
The TradingMarkets Swing Trading College Presentation
Wednesday November 18 01:00 PM
Hear What Gary Kaltbaum Sees in the Stock Market Today!
* Attendance is strictly limited and are filled on a first-come, first-served basis.
PREMIER SPONSORED LINKS
TRADE CENTER
The TradingMarkets Directory
Tax Relief Bank Levy Wage Garnishment
Disclaimer:
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
(c) Copyright 2009 The Connors Group, Inc.
I thought this page was interesting because:
| re:0.72 st:0.02 fo:0 s:0.01 d:3.41 c:0 db:0.193 a:0.69 m:0.04 t:5.31 (f) |
| ![:-] Bot! - home](/bot/images/dsbotface1.gif ":-] Bot! - home")
